Plus $4m value in a listed shell = $14m. And that assumes that they never do any better than they did in the past half. Thanks for your analysis, but we will have to agree to disagree.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come